Back to top
   Call Me Free Offline Send SMS Send Inquiry
Home » Products » Fresenius Kabi Oncology » Paclitaxel Injection Ip

Paclitaxel Injection Ip

Paclitaxel Injection Ip
Send Inquiry
Product Code : BM-06
Brand Name : BHOOMI MARKETING
Product Description
COMPOSITION:
Each ml contains:
Paclitaxel IP 6 mg
Polyoxyl 35 Castor Oil USNF 527 mg
Dehydrated  IP 49.7% v/v

INDICATIONS :
 
Paclitaxel Injection (INTAXEL) is indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As first-line therapy, Paclitaxel Injection is indicated in combination with cisplatin.
Paclitaxel Injection (INTAXEL) is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy.
Paclitaxel Injection (INTAXEL) is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.
Paclitaxel Injection (INTAXEL) in combination with cisplatin, is indicated for the first-line treatment of non-small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation therapy.
Paclitaxel Injection (INTAXEL) is indicated for the second-line treatment of AIDS- related Kaposi's sarcoma.
   
PRESENTATION: :
 
30 mg/5ml, 100 mg/17ml and 260 mg/43.4 ml vials individually packaged in a carton.

BHOOMI MARKETING CO.
X


BHOOMI MARKETING CO.
5, SUNDERVAN SOCIETY, NEAR NAVGUJARAT COLLEGE, ASHRAM ROAD, USMANPURA, Ahmedabad - 380014, Gujarat, India
Trust Stamp
Product Showcase
   Call Me Free Offline Send SMS Send Inquiry